GT201100074A - ANTIVIRAL COMPOUNDS - Google Patents

ANTIVIRAL COMPOUNDS

Info

Publication number
GT201100074A
GT201100074A GT201100074A GT201100074A GT201100074A GT 201100074 A GT201100074 A GT 201100074A GT 201100074 A GT201100074 A GT 201100074A GT 201100074 A GT201100074 A GT 201100074A GT 201100074 A GT201100074 A GT 201100074A
Authority
GT
Guatemala
Prior art keywords
compounds
antiviral compounds
hcv
elaboration
hepatitis
Prior art date
Application number
GT201100074A
Other languages
Spanish (es)
Inventor
David A Degoey
Warren M Kati
Charles W Hutchins
Pamela L Donner
Allan C Krueger
Christopher E Motter
Lissa T Nelson
Sachin V Patel
Mark A Matulenko
Ryan G Keddy
Tammie K Jinkerson
Todd N Soltwedel
Douglas K Hutchinson
Charles A Flentge
Wagner Rolf
Clarence J Maring
Michael D Tufano
David A Betebenner
Todd W Rockway
Liu Dachun
John K Pratt
Michael J Lavin
Sarris Kathy
Kevin R Woller
Seble H Wagaw
Jean C Califano
Li Wenke
Original Assignee
Abbott Lab
John Randolph
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab, John Randolph filed Critical Abbott Lab
Publication of GT201100074A publication Critical patent/GT201100074A/en

Links

Abstract

COMPUESTOS EFICACES PARA INHIBIR LA REPLICACIÓN DEL VIRUS DE LA HEPATITIS C, HCV. ESTA INVENCIÓN TAMBIÉN SE RELACIONA CON PROCESOS DE ELABORACIÓN DE TALES COMPUESTOS, CON COMPOSICIONES QUE COMPRENDEN A DICHOS COMPUESTOS Y CON MÉTODOS DE USO DE DICHOS COMPUESTOS PARA TRATAR UNA INFECCIÓN POR HCV.EFFECTIVE COMPOUNDS TO INHIBIT THE REPLICATION OF THE VIRUS OF HEPATITIS C, HCV. THIS INVENTION IS ALSO RELATED TO PROCESSES OF ELABORATION OF SUCH COMPOUNDS, WITH COMPOSITIONS THAT INCLUDE SUCH COMPOUNDS AND WITH METHODS OF USE OF SUCH COMPOUNDS TO TREAT AN INFECTION BY HCV.

GT201100074A 2009-06-11 2011-03-29 ANTIVIRAL COMPOUNDS GT201100074A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18629109P 2009-06-11 2009-06-11
US24283609P 2009-09-16 2009-09-16

Publications (1)

Publication Number Publication Date
GT201100074A true GT201100074A (en) 2013-09-11

Family

ID=51540819

Family Applications (1)

Application Number Title Priority Date Filing Date
GT201100074A GT201100074A (en) 2009-06-11 2011-03-29 ANTIVIRAL COMPOUNDS

Country Status (1)

Country Link
GT (1) GT201100074A (en)

Similar Documents

Publication Publication Date Title
DOP2013000185A (en) ANTIVIRAL COMPOUNDS
GT201300093A (en) ANTIVIRAL COMPOUNDS
CL2015003615A1 (en) Substituted nucleosides, nucleotides and analogs thereof.
CL2016000493A1 (en) Hcv polymerase inhibitors
CL2017001798A1 (en) Pyrazine compounds for the treatment of infectious diseases.
CL2014000612A1 (en) Compounds derived from macrocyclic prolines, inhibitors of hepatitis C virus serine proteases (vhc); pharmaceutical composition that includes them; and its use to treat a viral infection such as hepatitis C virus (vhc) infection.
CL2016000381A1 (en) Antiviral compounds
CL2015000870A1 (en) 2'-Chloro nucleoside analogs for HCV infection.
CL2014003634A1 (en) Hepatitis C virus inhibitors
CL2012000573A1 (en) Compounds derived from biphenyl-pyrrolidinyl-imidazole; pharmaceutical composition comprising them; its use in the treatment of an hcv viral infection.
CL2012001176A1 (en) Benzimidazole-imidazole derivative compounds, hepatitis c virus (hcv) inhibitors; pharmaceutical composition comprising them; pharmaceutical combination; use in the prevention or treatment of hcv infection.
PH12017500393A1 (en) Pyrrolopyrimidines for use in influenza virus infection
CL2012002489A1 (en) Compounds derived from silyl naphtho-imidazole; pharmaceutical composition; and its use to prevent or treat a hepatitis c virus infection.
CL2015001971A1 (en) Tetracyclic compounds substituted with heterocycle and methods of use thereof for the treatment of viral diseases.
GT200900097A (en) INHIBITORS OF HCV PROTEASE NS3.
CL2012001959A1 (en) Compounds derived from thiophene-2-carboxylic acid, flaviviridae virus inhibitors; pharmaceutical composition that includes them; and its use for the treatment of a viral infection by flaviviridae.
CR20120440A (en) HETEROCYCLIC POLICYCLY COMPOUNDS CAN BE USED AS EFFECTIVE INHIBITORS FOR HEPATITIS C VIRUSES
CL2013001141A1 (en) Compounds derived from condensed heterocycles, hepatitis c virus inhibitors; pharmaceutical composition that contains them; and its use for the treatment of hepatitis c virus infection.
ECSP11011310A (en) CARBA ANALOGS - NUCLEOSIDE FOR ANTIVIRAL TREATMENT
ECSP18061667A (en) PYRIMIDINES SUBSTITUTED WITH ARILO FOR USE IN INFECTION BY VIRUS INFLUENZA
CL2010001634A1 (en) Compounds derived from nucleosides, hepatitis c virus inhibitors; preparation procedure; pharmaceutical composition that includes them; and pharmaceutical combination.
UY32715A (en) USEFUL PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF HEPATITIS C (HCV) VIRUSES, USES AND RELATED METHODS
UY32721A (en) USEFUL PHARMACEUTICAL COMPOSITIONS TO TREAT HEPATITIS C (HCV) VIRUSES, USES AND RELATED METHODS
CL2014000393A1 (en) Compounds derived from benzofuran and its salts, as hepatitis c virus inhibitors; pharmaceutical composition that includes them; and its use for the treatment or prevention of an infection with the hepatitis c virus or a disease associated with said infection.
UY32720A (en) PHARMACEUTICAL COMBINATIONS USEFUL FOR THE TREATMENT OF HEPATITIS C (HCV) VIRUSES, USES AND RELATED METHODS